
    
      This is a randomized controlled, single-center study, with blinding of outcome assessors. A
      pilot study with ten patients was previously conducted in order to test study logistics and
      data collection instruments. Participants will be recruited from a public ED at Restinga
      district in Porto Alegre, southern Brazil.
    
  